Insulin Like Growth Factor (IGF) Inhibitors - Pipeline Insights, 2016


#532848

60pages

DelveInsight

$ 1250

In Stock

SUMMARY
DelveInsights, Insulin Like Growth Factor (IGF) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor (IGF) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Insulin Like Growth Factor (IGF) Inhibitors. DelveInsights Report also assesses the Insulin Like Growth Factor (IGF) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope